Skip Navigation



Nucleic Acids Research Advance Access published online on October 4, 2008

Nucleic Acids Research, doi:10.1093/nar/gkn678
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (8955K) Freely available
Right arrow Screen PDF (623K) Freely available
Right arrowOA All Versions of this Article:
36/20/6363    most recent
gkn678v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Dash, C.
Right arrow Articles by Le Grice, S. F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dash, C.
Right arrow Articles by Le Grice, S. F. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Nucleic Acid Enzymes

Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids

Chandravanu Dash1, Brian J. Scarth2, Christopher Badorrek1, Matthias Götte2 and Stuart F. J. Le Grice1,*

1HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA and 2Department of Microbiology and Immunology, McGill University, Montreal, Canada

*To whom correspondence should be addressed. Tel: +301 846 5502; Fax: +301 846 6013; Email: slegrice{at}ncifcrf.gov

Received July 22, 2008. Revised September 22, 2008. Accepted September 23, 2008.

The crystal structure of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) bound to an RNA/DNA hybrid reveals an extensive network of contacts with the phosphate backbone of the DNA strand ~4–9 bp downstream from the ribonuclease H (RNase H) catalytic center. Collectively designated as ‘the RNase H primer grip’, this motif contains a phosphate binding pocket analogous to the human and Bacillus halodurans RNases H. The notion that the RNase H primer grip mediates the trajectory of RNA/DNA hybrids accessing the RNase H active site suggests that locally neutralizing the phosphate backbone may be exploited to manipulate nucleic acid flexibility. To examine this, we introduced single and tandem methylphosphonate substitutions through the region of the DNA primer contacted by the RNase H primer grip and into the RNase H catalytic center. The ability of mutant hybrids to support RNase H and DNA polymerase activity was thereafter examined. In addition, site-specific chemical footprinting was used to evaluate movement of the DNA polymerase and RNase H domains. We show here that minor alteration to the RNase H primer can have a dramatic effect on enzyme positioning, and discuss these findings in light of recent crystallography of human RNase H containing an RNA/DNA hybrid.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. J. Schultz, M. Zhang, and J. J. Champoux
Preferred Sequences within a Defined Cleavage Window Specify DNA 3' End-directed Cleavages by Retroviral RNases H
J. Biol. Chem., November 20, 2009; 284(47): 32225 - 32238.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.